Clincosm LogoSign in Get a demo

Prevalence of Disruptive Behavior in Children With Attention Deficit Hyperactivity Disorder(ADHD)

Sponsor
Eman Sayed Hassan Mahros (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05070481
Collaborator
(none)
3
Enrollment
12
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Identification of prevalence and Risk factors for disruptive behavior in children with Attention Deficit Hyperactivity Disorder and Early recognition of disruptive behavior in children with ADHD

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    ADHD is asustaible pattern of inattention Hyperactivity and lmpulsive behavior which can have harmful consequences for the patients social life it was called childhood hyperkinetic reaction before it is estimated that 3 to 5 percent of children show symptoms in primary school in addition to the role of genetic factor in the incidence of this mental disorder ,family imbalance and other anxiety factors play arole in the continuity of disorder.disruptive behavior with a prevalence of 1 to 10percent is a prevalent disorder in primary school similar to ADHD it is 4 to 12 times more frequent among boys compared with girls . disruptive behavior characterized by aggression and violating others rights . This study is screening survey questionnaire study will be done in Assuit University children hospital Neuro psychiatric outpatient clinic in all children under 18 years old have ADHD and exclude other psychiatric problems as :Autism , depression , Schizophrenia or mental retardation . investigator will take full history : personal history : name , date of birth ,age,sex ,age of onset of ADHD ,type of ADHD,severity of ADHD ,type of disruptive behavior , history of treatment,Family history : sibling have ADHD,smoking of parents,drug use parents,social problems: divorce or death of parents . Investigator will use DSM V criteria as adignostic criteria and screening data evaluated by ADHD symptoms check list -4 (ADHD -sc4 scale scores) : symptoms count scores and symptoms severity scores . All for detect outcome of the patient with ADHD .

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    3 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Clinical Observational and Statistical Study for Detection of Prevalence and Risk Factors of Disruptive Behavior in Children With Attention Deficit Hyperactivity Disorder (ADHD)
    Anticipated Study Start Date :
    Oct 1, 2021
    Anticipated Primary Completion Date :
    Jun 1, 2022
    Anticipated Study Completion Date :
    Oct 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Assessment of prevalence of disruptive behavior in children with ADHD by Sc -4 scale and DSM V score [Primarily from October 2021 till June 2022]

      Screening data by ADHD symptoms chick list -4 rating scale(ADHD Sc-4 scale ) to detect symptoms count score and also invistigator use Diagnostic and Statistical Manual of mental disorders fifth edition(DSM V score) to assess the severity of symptoms

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Months to 1 Year
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All children under 18 years old with ADHD at Neuro pyshictric outpatient clinic
    Exclusion Criteria:
    • Any psychiatric problems other than ADHD like :Autism, depression, schizophrenia or mental retardation

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Eman Sayed Hassan Mahros

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Eman Sayed Hassan Mahros, Principal investigator, Assiut University
    ClinicalTrials.gov Identifier:
    NCT05070481
    Other Study ID Numbers:
    • 271087
    First Posted:
    Oct 7, 2021
    Last Update Posted:
    Oct 7, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Hyperkinesis
    Attention Deficit Disorder with Hyperactivity
    Problem Behavior

    Study Results

    No Results Posted as of Oct 7, 2021